Gf Fund Management Co. Ltd. Biomarin Pharmaceutical Inc Transaction History
Gf Fund Management Co. Ltd.
- $4.62 Trillion
- Q4 2024
A detailed history of Gf Fund Management Co. Ltd. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 4,002 shares of BMRN stock, worth $282,901. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,002Holding current value
$282,901% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding BMRN
# of Institutions
628Shares Held
183MCall Options Held
2MPut Options Held
1.67M-
Black Rock Inc. New York, NY22.7MShares$1.61 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.4MShares$1.37 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.2MShares$1.29 Billion0.94% of portfolio
-
Dodge & Cox San Francisco, CA14.7MShares$1.04 Billion0.61% of portfolio
-
Capital Research Global Investors Los Angeles, CA13MShares$918 Million0.18% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $13.1B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...